Sign in

Ramdev's Divya Pharmacy among 16 Indian pharma firms in Nepal's blacklist. Here's why

In a notice issued on December 18, the Department of Drug Administration asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them.

Published on: Dec 20, 2022, 22:19:50 IST
By , New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

Sixteen Indian pharma companies have been blacklisted by Nepal's drug regulatory authority for their "failure" to comply with the World Health Organization's drug manufacturing standards, media reports claimed on Tuesday.

Yoga guru Ramdev linked Divya Pharmacy among Indian campanies blacklisted by Nepal. (PTI Photo)
Yoga guru Ramdev linked Divya Pharmacy among Indian campanies blacklisted by Nepal. (PTI Photo)

In a notice issued on December 18, the Department of Drug Administration asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. The notice also mentions the names of pharma companies blacklisted (both Indian and foreign), and says that medicines manufactured by the listed companies cannot be imported or distributed in Nepal.

Also read | IMA slams Patanjali campaign as breach of medical ethics

Apart from Divya Pharmacy, which manufactures Yoga Guru Ramdev's Patanjali products, the list also includes Radiant Parenterals Ltd, Mercury Laboratories Ltd, Alliance Biotech, Captab Biotec, Aglowmed Ltd, Zee Laboratories, Daffodils Pharmaceuticals, GLS Pharma, Unijules Life Science, Concept Pharmaceuticals, Shree Anand Life Sciences, IPCA laboratories, Cadila Healthcare Ltd, Dial Pharmaceuticals and Mackur laboratories. The list also names a few foreign brands.

According to news agency PTI, the list was published after an inspection of the manufacturing facilities of the pharmaceutical companies that had applied to export their products to Nepal. The department had – in April and July – sent a team of drug inspectors to India to inspect the manufacturing facilities of pharmaceutical companies that had applied to supply their products to Nepal.

Earlier, the WHO issued a medical product alert over four cough syrups — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup — manufactured and exported by India's Maiden Pharma. The four cough syrups were said to be linked to at least 66 deaths of children in The Gambia.

(With PTI, bureau inputs)

  • HT News Desk
    ABOUT THE AUTHOR
    HT News Desk

    Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

Follow India news real-time updates and the latest news covered on Hindustan Times, featuring today's critical updates on Sonam Wangchuk LIVE and more across India.